Aura Biosciences is a biotechnology business based in the US. Aura Biosciences shares (AURA) are listed on the NASDAQ and all prices are listed in US Dollars. Aura Biosciences employs 88 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $9.44 |
|---|---|
| 52-week range | $5.99 - $12.44 |
| 50-day moving average | $7.48 |
| 200-day moving average | $8.02 |
| Wall St. target price | $19.80 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.87 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $9.44 from 2024-07-23
| 1 week (2024-07-17) | 2.39% |
|---|---|
| 1 month (2024-06-24) | 32.77% |
| 3 months (2024-04-24) | 32.96% |
| 6 months (2024-01-24) | 26.20% |
| 1 year (2023-07-24) | -18.69% |
|---|---|
| 2 years (2022-07-22) | -30.59% |
| 3 years (2021-07-20) | N/A |
| 5 years (2019-07-20) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -24.9% |
| Return on equity TTM | -40.43% |
| Profit margin | 0% |
| Book value | $4.22 |
| Market Capitalization | $429.5 million |
TTM: trailing 12 months
We're not expecting Aura Biosciences to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Aura Biosciences's shares have ranged in value from as little as $5.99 up to $12.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aura Biosciences's is 0.373. This would suggest that Aura Biosciences's shares are less volatile than average (for this exchange).
To put Aura Biosciences's beta into context you can compare it against those of similar companies.
Aura Biosciences, Inc. , a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmette"guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
A deep dive into the highlights and limitations of Frec.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.